KCG
PFE icon

Knight Capital Group’s Pfizer PFE Stock Holding History

Knight Capital Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$8.53M Buy
+320,892
New +$8.87M 0.16% 77

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Knight Capital Group's PFE Position: Q2 2013 in Review

Knight Capital Group opened a new position in Pfizer (PFE) in Q2 2013: 320,892 shares worth $8.53M. The stake represents 0.16% of the portfolio and ranks #77 among its holdings.

1,626 funds tracked by Wall St. Rank hold PFE as of Q2 2013.

  • Knight Capital Group held 320,892 shares of Pfizer worth $8.53M as of Q2 2013.
  • Pfizer was a new Knight Capital Group position in Q2 2013.
  • Pfizer made up 0.16% of Knight Capital Group's portfolio in Q2 2013, its #77 holding.
  • 1,626 funds tracked by Wall St. Rank held Pfizer as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.